coumarin has been researched along with Coronary Disease in 27 studies
2H-chromen-2-one: coumarin derivative
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At coronary angiography <48 hours after fibrinolytic therapy, 308 patients receiving aspirin and intravenous heparin had a patent infarct-related artery (Thrombolysis In Myocardial Infarction [TIMI] grade 3 flow)." | 9.10 | Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. ( Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP, 2002) |
| "At coronary angiography <48 hours after fibrinolytic therapy, 308 patients receiving aspirin and intravenous heparin had a patent infarct-related artery (Thrombolysis In Myocardial Infarction [TIMI] grade 3 flow)." | 5.10 | Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. ( Aengevaeren, WR; Brouwer, MA; Hertzberger, DP; Luijten, HE; Uijen, GJ; van Boven, AJ; van den Bergh, PJ; Veen, G; Verheugt, FW; Vromans, RP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (88.89) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FALK, OP | 1 |
| Brouwer, MA | 1 |
| van den Bergh, PJ | 1 |
| Aengevaeren, WR | 1 |
| Veen, G | 1 |
| Luijten, HE | 1 |
| Hertzberger, DP | 1 |
| van Boven, AJ | 1 |
| Vromans, RP | 1 |
| Uijen, GJ | 1 |
| Verheugt, FW | 1 |
| POLLITZER, RS | 2 |
| LUND, E | 1 |
| SMITH, DS | 1 |
| KOZONIS, MC | 1 |
| OWREN, PA | 1 |
| SCHMIDT-ELMENDORFF, H | 1 |
| LOPES CARDOZO, E | 1 |
| TOOHEY, M | 1 |
| RAYNAUD, R | 1 |
| BERNASCONI, P | 1 |
| AFANAS'EV, GG | 1 |
| BELIAEVA, EL | 1 |
| BAER, S | 1 |
| YARROW, MW | 1 |
| KRAVITZ, C | 1 |
| MARKSON, V | 1 |
| MEYER, OO | 1 |
| DESROCHERS, Y | 1 |
| AERICHIDE, N | 1 |
| DAVID, P | 1 |
| STROM, CH | 1 |
| COCHRAN, WN | 1 |
| TOSTES, LR | 1 |
| RIBEIRO, AP | 1 |
| da RAPOSO, JS | 1 |
| SALES NETO, M | 1 |
| FAIVRE, G | 1 |
| GILGENKRANTZ, JM | 1 |
| CHERRIER, F | 1 |
| TENETTE, C | 1 |
| BARRUCAND, D | 1 |
| HOLTEN, C | 1 |
| TULLOCH, JA | 1 |
| GILCHRIST, AR | 1 |
| SMITH, KS | 1 |
| PAPP, C | 1 |
| SHAPIRO, S | 1 |
| GORINSHTEIN, ML | 1 |
| KASATKIN, EV | 1 |
| MERKUL', VE | 1 |
| FIL'KOVA, EM | 1 |
| SCOTT, M | 1 |
| MENDEZ, L | 1 |
| ZAJARIAS, S | 1 |
| DELGADO, A | 1 |
| Fitzgerald, PJ | 1 |
| Oshima, A | 1 |
| Hayase, M | 1 |
| Metz, JA | 1 |
| Bailey, SR | 1 |
| Baim, DS | 1 |
| Cleman, MW | 1 |
| Deutsch, E | 1 |
| Diver, DJ | 1 |
| Leon, MB | 1 |
| Moses, JW | 1 |
| Oesterle, SN | 1 |
| Overlie, PA | 1 |
| Pepine, CJ | 1 |
| Safian, RD | 1 |
| Shani, J | 1 |
| Simonton, CA | 1 |
| Smalling, RW | 1 |
| Teirstein, PS | 1 |
| Zidar, JP | 1 |
| Yeung, AC | 1 |
| Kuntz, RE | 1 |
| Yock, PG | 1 |
| van Oppen, J | 1 |
| van Ommen, V | 1 |
| Bär, FW | 1 |
| de Swart, JB | 1 |
| van der Veen, FH | 1 |
| Wellens, HJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Gemini Angioplasty and Arterial Measurement Evaluation (GAAME) An Evaluation of the Metricath Gemini System, a Percutaneous Interventional Device Intended to Make Arterial Lumen Measurements and Perform Percutaneous Transluminal Angioplasty Dilations.[NCT00399646] | Phase 2 | 145 participants (Actual) | Interventional | 2005-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for coumarin and Coronary Disease
| Article | Year |
|---|---|
Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Topics: Anticoagulants; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Disease-Free Survival; D | 2002 |
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study.
Topics: Aspirin; Coronary Angiography; Coronary Disease; Coronary Vessels; Coumarins; Female; Fibrinolytic A | 2000 |
25 other studies available for coumarin and Coronary Disease
| Article | Year |
|---|---|
Treatment of coronary artery disease; dicumarol therapy.
Topics: Coronary Artery Disease; Coronary Disease; Coronary Vessels; Coumarins; Dicumarol; Disease | 1947 |
Ethyl biscoumacetate (tromexan) in coronary artery disease.
Topics: Coronary Artery Disease; Coronary Disease; Coumarins; Diuretics; Ethyl Biscoumacetate; Humans | 1953 |
Long term dicumarol therapy in thromboembolic conditions, especially coronary thrombosis.
Topics: Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol; Embolism; Thromboembolism | 1953 |
Dicumarol therapy in the treatment of status angina and impending coronary thrombosis.
Topics: Angina Pectoris; Coronary Disease; Coronary Thrombosis; Coumarins; Dicumarol | 1953 |
Long term anticoagulant therapy in coronary artery disease.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Cardiotonic Agents; Coronary Artery Disease; Coronary Diseas | 1954 |
[Anticoagulants in myocardial infarct after coronary thrombosis].
Topics: Anticoagulants; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Myocardial Infarction | 1954 |
[Further experience with prolonged dicumarol therapy of coronary thrombosis].
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; Coumarins; Dicuma | 1955 |
Phenylpropyl-hydroxycoumarin as an anticoagulant.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Disease; Coumarins; Thrombosis | 1956 |
[Acute angina and anticoagulants].
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Cardiotonic Agents; Coronary Disease; Couma | 1955 |
[Neodicoumarin therapy of patients with coronary insufficiency].
Topics: Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Coumarins; Glycosides | 1956 |
[Treatment of coronary insufficiency with dicoumarin].
Topics: Coronary Artery Disease; Coronary Disease; Coumarins; Dicumarol | 1956 |
Clinical experiences with warfarin (coumadin) sodium as an anticoagulant.
Topics: Anticoagulants; Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction; Sodium; Warfa | 1958 |
Use of anticoagulants in the treatment of coronary artery disease.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Artery Disease; Coronary Disease; Coumarins; Humans | 1958 |
Anticoagulant therapy; clinical experience with acenocoumarin (Sintrom) and other coumarin derivatives.
Topics: Acenocoumarol; Anticoagulants; Coronary Disease; Coumarins; Humans | 1959 |
The anticoagulant sintrom (acenocoumarin) in coronary artery disease; clinical experience.
Topics: Acenocoumarol; Anticoagulants; Coronary Artery Disease; Coronary Disease; Coumarins; Humans | 1959 |
[Study of a new coumarin anticoagulant, compound G-23350 (Sintrom)].
Topics: Acenocoumarol; Anticoagulants; Coronary Disease; Coumarins; Peripheral Vascular Diseases; Thromboemb | 1960 |
[CRITICAL STUDY, BASED ON 43 CASES, OF A COUMARIN ANTICOAGULANT: DICOUMOXYL (1-METHOXY-2,2-BIS-(4-HYDROXY-3-COU- MARINYL)-ETHANE)].
Topics: Anticoagulants; Arrhythmias, Cardiac; Coronary Disease; Coumarins; Ethane; Mitral Valve Stenosis; My | 1963 |
Anticoagulants in the treatment of coronary thrombosis.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Coronary Disease; Coronary Thrombosis; Coumarins; Heparin; H | 1951 |
Tromexan in the treatment of coronary thrombosis.
Topics: Cardiotonic Agents; Coronary Disease; Coronary Thrombosis; Coumarins; Ethyl Biscoumacetate; Humans | 1951 |
The prevention of impending cardiac infarction by anticoagulant treatment.
Topics: Angina, Unstable; Anticoagulants; Coronary Disease; Coumarins; Heparin; Humans; Infarction; Myocardi | 1951 |
Oral anticoagulant therapy in myocardial infarction.
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
[Treatment with dicoumarin of myocardial infarction; preliminary communication].
Topics: Coronary Disease; Coumarins; Dicumarol; Humans; Myocardial Infarction | 1952 |
Dicoumarol in general practice.
Topics: Coronary Disease; Coumarins; Dicumarol; Family Practice; Humans | 1952 |
[Anticoagulants in the treatment of myocardial infarction].
Topics: Anticoagulants; Coronary Disease; Coumarins; Myocardial Infarction | 1951 |
Complications after intracoronary stent implantation: three cases.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Disease; Coumarins; Di | 1992 |